High-risk Oral Precancerous Disease
📧 Sign up to get email alerts when something new happens for High-risk Oral Precancerous Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease [Phase 2]
RP2 is being studied as an immunoprevention agent for high-risk oral precancerous disease in a Phase II trial that is currently recruiting.